November 12, 2024- Baxter provided a U.S. Supply Continuity update on IV solutions on November 11, stating that the company has “further communicated with customers that, barring any unanticipated developments, it expects to reach 100% allocation across several IV product codes by the end of the year. The November 11 communication includes additional details on planned, phased increases in allocations in late November, mid-December and end of year.”
“The anticipated allocation changes across these IV product codes are based on 1) the current and projected status of our North Cove remediation efforts, 2) our expectations regarding our ability to reallocate capacity from other Baxter facilities, and 3) temporary importation on certain products. Allocation adjustments will be communicated to customers ahead of the expected effective dates,” according to Baxter.
The company also provided resources for healthcare professionals and customers on conservation and medical information, which can be accessed here.